San Diego, CA -- (SBWire) -- 06/20/2023 --Certain directors of Ascendis Pharma A/S are under investigation over potential breaches of fiduciary duties by certain directors.
Investors who purchased shares of Ascendis Pharma A/S (NASDAQ: ASND) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Ascendis Pharma A/S directors breached their fiduciary duties and caused damage to the company and its shareholders.
Denmark based Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. On April 3, 2023, before market hours, Ascendis Pharma A/S announced that the "U.S. Food & Drug Administration ("FDA") has notified the Company that, as part of their ongoing review, the FDA has identified deficiencies in the Company's New Drug Application ("NDA") for TransCon PTH (palopegteriparatide) in hypoparathyroidism that at this time precludes them from holding further discussions about labeling and post-marketing requirements/commitments. The deficiencies were not disclosed in the letter."
Shares of Ascendis Pharma A/S (NASDAQ: ASND) declined from $134.52 per share in November 11, 2022, to as low as $64.33 per share on April 3, 2023.
Those who purchased shares of Ascendis Pharma A/S (NASDAQ: ASND) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ: ASND Investor Alert: Investigation over Potential Wrongdoing at Ascendis Pharma A/S
An investigation on behalf of investors in Ascendis Pharma A/S (NASDAQ: ASND) shares over potential wrongdoing at Ascendis Pharma A/S was announced.